Publications by authors named "Guangyan Mu"

Claim this Profile
A
Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study.
Shan Chong, Lan Sun, Guangyan Mu, Manqi Hua, Qian Xiang

Paediatr Drugs· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of an Integrated Population Pharmacokinetic/ Pharmacodynamics Model of Apixaban in Chinese Healthy Population Adjusting for Key Genetic Variants.
Guangyan Mu, Yaou Liu, Qiufen Xie, Zhiyan Liu, Hanxu Zhang

Curr Pharm Des· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants associated with physiological and biochemical indicators: A multi-centre whole-exome sequencing study of Chinese healthy participants.
Zhe Wang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Shuang Zhou

Clin Transl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review).
Shan Chong, Guangyan Mu, Xinan Cen, Qian Xiang, Yimin Cui

Int J Mol Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Pharmacogenetic Variability Associated with the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study.
Zhiyan Liu, Qiufen Xie, Xia Zhao, Yunlong Tan, Wenping Wang, Guangyan Mu

Clin Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-type lectin-like receptor 2: roles and drug target.
Lan Sun, Zhe Wang, Zhiyan Liu, Guangyan Mu, Yimin Cui

Thromb J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome.
Wenhui Li, Shuang Zhou, Hanxu Zhang, Zhe Wang, Guangyan Mu

Clin Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal anti-platelet therapy for older patients with acute coronary syndrome: a network meta-analysis of randomized trials comprising 59,284 older patients.
Shuang Zhou, Wenhui Li, Qian Xiang, Zhe Wang, Hanxu Zhang, Guangyan Mu

J Thromb Thrombolysis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients.
Shuang Zhou, Zhe Wang, Zhiyan Liu, Guangyan Mu, Qiufen Xie

Cardiovasc Drugs Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study.
Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu

Clin Transl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary Syndrome.
Zhiyan Liu, Yaou Liu, Guangyan Mu, Hanxu Zhang, Shuang Zhou

Clin Pharmacokinet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF.
Zhi-Yan Liu, Min-Xue Sun, Man-Qi Hua, Han-Xu Zhang, Guang-Yan Mu

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of genetic biomarkers associated with pharmacokinetics and pharmacodynamics of apixaban in Chinese healthy volunteers.
Guangyan Mu, Qiufen Xie, Zhiyan Liu, Hanxu Zhang, Xianmin Meng

Expert Opin Drug Metab Toxicol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor.
Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu

Pharmacotherapy· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort study.
Qian Xiang, Qiufen Xie, Zhiyan Liu, Guangyan Mu, Hanxu Zhang

Clin Transl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban.
Hanxu Zhang, Zhuo Zhang, Zhiyan Liu, Guangyan Mu, Qiufen Xie

Hum Genomics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population.
Fan Zhang, Guangyan Mu, Zhiyan Liu, Qiufen Xie, Hanxu Zhang

Genes (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferroptosis of Endothelial Cells in Vascular Diseases.
Hanxu Zhang, Shuang Zhou, Minxue Sun, Manqi Hua, Zhiyan Liu, Guangyan Mu

Nutrients· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation.
Ya-Ou Liu, Qiu-Fen Xie, Zhi-Yan Liu, Zhe Wang, Guang-Yan Mu

Front Cardiovasc Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoclot Thrombin Inhibitor Assay and Expected Peak-Trough Levels of Dabigatran: A Multicenter Study.
Zhiyan Liu, Guangyan Mu, Qiufen Xie, Hanxu Zhang, Jie Jiang

Front Cardiovasc Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects.
Qian Xiang, Zhiyan Liu, Guangyan Mu, Qiufen Xie, Hanxu Zhang

Clin Drug Investig· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
,
, , and Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population.
Qiufen Xie, Yuan Li, Zhiyan Liu, Guangyan Mu, Hanxu Zhang

Front Genet· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies.
Zhi-Yan Liu, Han-Xu Zhang, Ling-Yue Ma, Guang-Yan Mu, Qiu-Fen Xie

BMC Cardiovasc Disord· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis.
Qiufen Xie, Qian Xiang, Zhiyan Liu, Guangyan Mu, Shuang Zhou

BMC Cardiovasc Disord· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Risk of Oral Leukoplakia: A Meta-analysis.
Jiayi Wang, Chunsu Zhu, Guangyan Mu, Qian Xiang, Yimin Cui

Genet Test Mol Biomarkers· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis